Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02869581

Institut Paoli-Calmettes Pancreatic Neoplasms Database

Database of Institut Paoli Calmettes diagnosed with Pancreatic neoplasms

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut Paoli Calmettes

Marseille, Bouches du Rhone, 13009, France

Location status: Recruiting

Location contact

Dominique GENRE, MD

CONTACT

[email protected]

33 4 91 22 37 78

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with a diagnosis of Pancreatic neoplasm

Exclusion criteria

  • Patient with a diagnosis of cholangiocarcinoma

Treatment and study plan

Data Collection

Other

Primary outcomes

  1. Survival of patients with pancreatic neoplasms

    Time frame: 10 years

    Overall survival of all patients who come in the center

Secondary outcomes

  1. Collection of patients characteristics

    Time frame: 10 years

    Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies

Study contacts

Contact information is provided by the study sponsor or research team.

Dominique Genre, MD

CONTACT

[email protected]

0033491223778

Lilian Laborde

CONTACT

[email protected]

0033491223778

Sponsors and collaborators

Lead sponsor

Institut Paoli-Calmettes

Other

Registry information

Important dates

Study start
2000
Primary completion
2030
Study completion
2030
First posted
Aug 17, 2016
Registry last updated
Aug 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.